/People

Lyn Baranowski

CEO at Avalyn Pharma Inc

Boston, Massachusetts, United States

Find your path to Lyn

Sign up to see every warm intro you have to Lyn

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Lyn. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Lyn Baranowski is the Chief Executive Officer of Avalyn Pharma Inc. (NASDAQ: AVLN), a clinical-stage biopharmaceutical company developing inhaled therapies for rare lung diseases, including pulmonary fibrosis and other interstitial lung diseases. She has over 20 years of biopharma experience, has raised more than $620 million for Avalyn including its 2026 IPO, and previously contributed to the development and commercialization of therapies such as BREZTRI, BEVESPI, XOLAIR, TOBI, RECLAST, and BAXDELA. Baranowski holds an MBA from Harvard Business School, serves on the Board of Advisors for Life Science Cares, and was a 2024 PharmaVoice 100 award recipient.

Frequently asked questions

Who is Lyn Baranowski?
Lyn Baranowski is the Chief Executive Officer of Avalyn Pharma Inc. (NASDAQ: AVLN), a clinical-stage biopharmaceutical company developing inhaled therapies for rare lung diseases, including pulmonary fibrosis and other interstitial lung diseases. She has over 20 years of biopharma experience, has raised more than $620 million for Avalyn including its 2026 IPO, and previously contributed to the development and commercialization of therapies such as BREZTRI, BEVESPI, XOLAIR, TOBI, RECLAST, and BAXDELA. Baranowski holds an MBA from Harvard Business School, serves on the Board of Advisors for Life Science Cares, and was a 2024 PharmaVoice 100 award recipient.

Founder mafias

About this profile. Compiled from public sources — the organisations' own websites and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights